Prehabilitation for Breast Cancer Surgery

July 27, 2023 updated by: Raquel Sebio

Prehabilitation Program Based on Health Education and Nordic Walking to Reduce Musculoskeletal Impairments in Women Undergoing Breast Cancer Surgery

Prehabilitation for women diagnosed with breast cancer is commonly not part of the clinical pathways as little time (usually a few days) is left between diagnosis and surgery. However, a great proportion of these patients will undergo neoadjuvant chemotherapy which provides a window opportunity to improve patients' physical status to withstand surgery and minimize post-operative musculoskeletal complications associated with surgery.

To this end, the aim of this study is to assess the efficacy of a prehabilitation program consisting of health education and a supervised nordic walking-based intervention in women diagnosed with breast cancer currently undergoing neoadjuvant chemotherapy to decrease post-operative musculoskeletal impairments and improve functionality of the affected arm.

The study is an open-label, single-blind randomised controlled trial conducted at one tertiary hospital. Women diagnosed with breast cancer scheduled for surgery and currently undergoing chemotherapy will be randomised to either usual care (UC) or prehabilitation (PREHAB). Patients will be assessed for eligibility during the fourth out of six course of chemotherapy. Those randomised to the PREHAB group will participate in a supervised group-based nordic walking intervention twice weekly during 8 weeks (approximately 16 sessions). In addition, participants will receive written information regarding the benefits of exercise during cancer treatment and surveillance. Patients will be assessed prior to surgery as well as at 1, 3 and 6 months postoperatively.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Barcelona, Spain, 08041
        • Recruiting
        • Hospital Santa Creu i Sant Pau
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of breast cancer scheduled for surgery with or without lymphadenectomy
  • Candidates to receive neoadjuvant chemotherapy
  • Not currently undergoing any other physical therapy therapies or treatments

Exclusion Criteria:

  • Cognitive impairment or inability to read Catalan or Spanish
  • Prior diagnosis of shoulder impairment or injury
  • Major musculoskeletal, neurological or cardiorespiratory limitations to prevent participation in the exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
Patients allocated to this arm will continue with their schedule chemotherapy with no additional intervention
Experimental: Prehabilitation
Patients allocated to this arm will participate in a weekly group-based exercise intervention (nordic walking) and receive health education through a booklet, videos of the exercises and face-to-face sessions prior to each nordic walking session. Chemotherapy will continue as scheduled.
An exercise intervention based on nordic walking and health education of one hour and 15 minutes per session. Each session includes 10 min of health education followed by 15 minutes of warm-up exercises, 30 minutes of nordic walking and finally 15 min to cool-down. The intervention is meant to last during two months (last round of chemotherapy and one month pre-surgery), twice weekly for approximately a total of 16 sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: Pre-Surgery (one week)
Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability)
Pre-Surgery (one week)
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: One month post-surgery
Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability)
One month post-surgery
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: Three months post-surgery
Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability)
Three months post-surgery
Disabilities of the Arm Shoulder and Hand Questionnaire (Quick DASH)
Time Frame: Six months post-surgery
Functionality of the affected upper arm using the DASH questionnaire. The questionnaire compromises 11 items. Scoring ranges from 0 (no disability) to 100 (more severe disability)
Six months post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper arm volume
Time Frame: Pre-Surgery (one week)
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
Pre-Surgery (one week)
Upper arm volume
Time Frame: One month post-surgery
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
One month post-surgery
Upper arm volume
Time Frame: Three months post-surgery
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
Three months post-surgery
Upper arm volume
Time Frame: Six months post-surgery
Perimeter of the affected arm will be measured with a tape measure at hand, wrist, elbow and shoulder level
Six months post-surgery
Range of Movement (ROM)
Time Frame: Pre-Surgery (one week)
Range of movement of the affected arm in three axes using a goniometer
Pre-Surgery (one week)
Range of Movement (ROM)
Time Frame: One month post-surgery
Range of movement of the affected arm in three axes using a goniometer
One month post-surgery
Range of Movement (ROM)
Time Frame: Three months post-surgery
Range of movement of the affected arm in three axes using a goniometer
Three months post-surgery
Range of Movement (ROM)
Time Frame: Six months post-surgery
Range of movement of the affected arm in three axes using a goniometer
Six months post-surgery
Pain severity
Time Frame: Pre-Surgery (one week)
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
Pre-Surgery (one week)
Pain severity
Time Frame: One month post-surgery
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
One month post-surgery
Pain severity
Time Frame: Three months post-surgery
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
Three months post-surgery
Pain severity
Time Frame: Six months post-surgery
Global pain assessed with a Visual Analog Scale (0 no pain to 10 maximum pain)
Six months post-surgery
Health-Related Quality of Life
Time Frame: Pre-Surgery (one week)
Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life
Pre-Surgery (one week)
Health-Related Quality of Life
Time Frame: One month post-surgery
Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life
One month post-surgery
Health-Related Quality of Life
Time Frame: Three months post-surgery
HHealth-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life
Three months post-surgery
Health-Related Quality of Life
Time Frame: Six months post-surgery
Health-Related Quality of Life will be assessed with the questionnaire developed by the European Organization for Research and Treatment (EORTC) Quality of Life (QLQ) questionnaire (EORTC QLQ C30). Scores range from 0 to 100 with higher values associated with better overall quality of life
Six months post-surgery
Handgrip Strength
Time Frame: Pre-Surgery (one week)
Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used.
Pre-Surgery (one week)
Handgrip Strength
Time Frame: One month post-surgery
Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used.
One month post-surgery
Handgrip Strength
Time Frame: Three months post-surgery
Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used.
Three months post-surgery
Handgrip Strength
Time Frame: Six months post-surgery
Handgrip strength will be determined using an hydraulic dynamometer (Jamar). Both hands will be assessed and the better result out of three attempts will be used.
Six months post-surgery
Functional capacity
Time Frame: Pre-surgery (one week)
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
Pre-surgery (one week)
Functional capacity
Time Frame: One month post-surgery
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
One month post-surgery
Functional capacity
Time Frame: Three months post-surgery
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
Three months post-surgery
Functional capacity
Time Frame: Six months post-surgery
Functional capacity will be measured with the distance covered by the 6-Minute Walk Test.
Six months post-surgery
Adherence
Time Frame: Pre-Surgery (one week)
Adherence to the scheduled sessions will be registered in the Prehab group and will be reported as percentage of attended vs. scheduled.
Pre-Surgery (one week)
Physical Activity
Time Frame: Pre-surgery (one week)
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas.
Pre-surgery (one week)
Physical Activity
Time Frame: One month post-surgery
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas.
One month post-surgery
Physical Activity
Time Frame: Three months post-surgery
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas.
Three months post-surgery
Physical Activity
Time Frame: Six months post-surgery
Physical activity levels will be measured using the short form of the International Physical Activity Questionnaire (IPAQ). Estimated METS per week will be calculated based on the available formulas.
Six months post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Raquel Sebio, PhD, School of Health Sciences TecnoCampus. University Pompeu Fabra

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Estimated)

October 1, 2023

Study Completion (Estimated)

November 1, 2023

Study Registration Dates

First Submitted

January 18, 2022

First Submitted That Met QC Criteria

January 18, 2022

First Posted (Actual)

January 31, 2022

Study Record Updates

Last Update Posted (Actual)

July 28, 2023

Last Update Submitted That Met QC Criteria

July 27, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IIBSP-PRO-2021-10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Group-based Nordic Walking Exercise Program

3
Subscribe